FDA accepts filing of NDA for voclosporin as a treatment for lupus nephritis.- Aurinia Pharma
Aurinia Pharmaceuticals Inc., a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, announced that the FDA has accepted the filing of its New Drug Application… read more.
